Sucralfate
Code | Size | Price |
---|
TAR-T1338-100mg | 100mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T1338-1mL | 1 mL * 10 mM (in DMSO) | £115.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T1338-500mg | 500mg | £124.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Sucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.
CAS:
54182-58-0
Formula:
C11H407Al9O215S8
Molecular Weight:
4481.48
Pathway:
Tyrosine Kinase/Adaptors; ; Microbiology/Virology; Immunology/Inflammation; Angiogenesis; GPCR/G Protein
Purity:
0.98
SMILES:
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].[AlH3].OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(O)(=O)=O)O[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
Target:
FGFR; Antibacterial; Prostaglandin Receptor
References
1. Watanabe K, et al. Antimicrob Agents Chemother. 2004, 48(12):4582-8.
2. Matsuu-Matsuyama M, et al. J Radiat Res. 2006, 47(1):1-8.
3. Emenaker NJ, et al. Digestion. 1997, 58(1):34-42.
4. Furukawa O, et al. J Gastroenterol Hepatol. 1997, 12(5):353-9.